Receptor-interacting protein kinase 1 (RIPK1) is a major upstream mediator of inflammation and cell death. These processes are key to common inflammatory diseases such as atherosclerosis, where macrophages play an important role in their progression. Closely linked to the expression of downstream genes, long non-coding RNAs (lncRNAs) are critical to controlling cellular processes in health and disease. As post-transcriptional regulatory mechanisms for RIPK1 are largely unknown, this project seeks to study the stability of Ripk1 mRNA and RIPK1 protein, along with Ripk1 mRNA interactions with relevant lncRNAs under various conditions. Using transcription and translation inhibitors, we determined that both Ripk1 mRNA and RIPK1 protein are relatively unstable with half-lives of approximately 3 h. Their turnover in macrophages is further influenced by the timing and duration of inflammation. We also implemented a novel RNA pull-down procedure to capture Ripk1 mRNA and attached lncRNAs for next-generation sequencing. Through differential expression analysis, we discovered significant upregulation of known lncRNA AC125611 and novel lncRNA MSTRG.5894.1 in Ripk1-targeted samples subject to inflammation. MSTRG.7477.1 was upregulated during necroptosis, while MSTRG.5684.5 was upregulated during both inflammation and necroptosis. GapmeR-mediated knockdowns of AC125611 and MSTRG.5684.5 under inflammatory conditions resulted in decreased Ripk1 mRNA expression and RIPK1 protein expression, respectively. Meanwhile, MSTRG.7477.1 knockdowns were connected to decreased RIPK1 at both the mRNA and protein levels. Our research ultimately advances the current understanding of RIPK1 regulation by focusing on Ripk1 mRNA-lncRNA associations and turnover of its mRNA and protein in macrophages, paving the way for future investigations into their capacity to act as therapeutic targets.

RNAs play essential roles in various biological processes. Mounting evidence has demonstrated that RNA subcellular localization and intercellular trafficking govern their functions in coordinating plant growth at the organismal level. Beyond that, plants constantly encounter foreign RNAs (i.e., RNAs from pathogens including viruses and viroids). The subcellular localizations of RNAs are crucial for their function. While numerous types of RNAs (i.e., mRNAs, small RNAs, rRNAs, tRNAs, and long noncoding RNAs) have been found to traffic in a non-cell-autonomous fashion within plants, the underlying regulatory mechanism remains unclear. Viroids are single-stranded circular noncoding RNAs, which entirely rely on their RNA motifs to exploit cellular machinery for organelle entry and exit, cell-to-cell movement through plasmodesmata, and systemic trafficking. Viroids represent an excellent model to dissect the role of RNA 3-dimensional (3D) structural motifs in regulating RNA movement. Using nuclear-replicating viroids as a model, we showed that cellular Importin alpha-4 is likely involved in viroid RNA nuclear import, empirically supporting the involvement of Importin-based cellular pathway in RNA nuclear import. We also confirmed the involvement of a cellular protein (Virp1) that binds both Importin alpha-4 and viroids. Moreover, a conserved C-loop in nuclear-replicating viroids serves as a key signal for nuclear import. Disrupting C-loop impairs Virp1 binding, viroid nuclear accumulation and infectivity. Further, C-loop exists in a subviral satellite noncoding RNA that relies on Virp1 for nuclear import. On the other hand, no viroid can systemically infect the model plant Arabidopsis thaliana, suggesting the existence of non-host resistance yet to be understood. Here, we attempted to test whether a gene involved in RNA silencing, RNA-dependent RNA polymerase 6 (RDR6), plays a role in non-host resistance in Arabidopsis. I will discuss the data below in detail.

No description available.

No description available.

<p>Bacterial small RNAs have emerged as a class of molecules having important regulatory roles. Accumulating numbers of <em>cis</em>-encoded sRNAs (antisense RNAs) have been recently discovered to be transcribed from the chromosomal DNA of many bacterial species, including the streptomycetes. Here, we investigate potential regulatory roles for two <em>S. coelicolor</em> antisense RNAs, scr4677 and α-abeA.</p> <p>The scr4677 antisense RNA is transcribed from the intergenic region between <em>SCO4676</em> (a gene encoding a conserved protein of unknown function) and <em>SCO4677</em>, encoding a regulatory protein with proposed anti-sigma factor activity. Transcription profiling revealed that scr4677 may not only interact with <em>SCO4676</em> mRNA but also with <em>SCO4677-4676</em> read-through transcripts. Our study suggested that scr4677 functioned to destabilize <em>SCO4676</em> mRNA, at the same time that it stabilized the <em>SCO4677-4676</em> read-through transcript. The potential role for scr4677 in destabilizing <em>SCO4676</em> mRNA was not mediated by the double stranded ribonuclease RNase III. Genetic analysis showed <em>scr4677</em> transcription was affected by SCO4677, and the transcription was apparently dependent on an unknown protein binding to the <em>SCO4676 </em>coding sequence.</p> <p>A second independent study focused on investigating the regulation of a previously uncharacterized genetic region, <em>SCO3287-3290</em>, since renamed <em>abeABCD</em>. This region contains an antisense RNA (α-abeA)-encoding gene, and is adjacent to the downstream <em>SCO3291</em> (<em>abeR</em>) gene, which encodes a putative regulatory protein. Genetic analysis revealed that overexpression of <em>abeR </em>or <em>abeABCD</em> stimulated the production of the blue-pigmented antibiotic actinorhodin, and deletion of <em>abeR</em> impaired actinorhodin production. Transcription analysis revealed the <em>abe</em> genes (including α-<em>abeA</em>) to be subject to multiple levels of regulation. We found an internal promoter within the <em>abeA</em> coding sequence and that required AbeR for expression. Furthermore, biochemical experiments demonstrated that AbeR regulated <em>abeBCD</em> directly, by binding to four heptameric repeats in its promoter region. The expression of α-<em>abeA</em> and other <em>abe</em> genes were differentially affected by RNase III.</p> / Doctor of Science (PhD)

Epigenetics was a term first coined to understand how cells with the same genetic make up can differentiate into various cell types. Elegant research over the past 30 years has shown that these mechanisms include heritable marks such as DNA methylation and histone modifications along with stable expression of non- coding RNAs. Within the realm of epigenetics is a phenomenon known as genomic imprinting. Imprints are marks that distinguish the maternal from the paternal chromosomes in the form of methylation. Methylation marks can influence transcript expression, resulting in only one allele being expressed. One imprinted domain is the Kcnq1 domain located on chromosome 11p15.5 in humans and chromosome 7 in the mouse. This domain is thought to be under the control of a paternally expressed long noncoding RNA (ncRNA) Kcnq1ot1. The Kcnq1ot1 ncRNA is expressed on the paternal chromosome due to a differentially methylation region located within its promoter. The promoter is methylated on the maternal allele thus inhibiting ncRNA expression, whereas the promoter is unmethylated on the paternal allele. In the placenta, a most of the genes located within a one mega-basepair region are exclusively expressed from the maternal chromosome, whereas the transcripts on the paternal chromosome are silenced by the ncRNA. The placenta seems to follow the classic idea of an imprinted domain. However, in the embryo and more specifically, in the embryonic heart, this is not the case. In the embryonic heart, only a 400kb region is restricted to maternal expression. In addition, one the genes, Kcnq1, starts out expressed exclusively from the maternal allele in early development but switches to biallelic expression during mid-gestation. The purpose of my research is to determine the underlying complexities that are involved in the regulation of transcripts within the Kcnq1 domain. This involves the Kcnq1 gene itself, which has been shown to transition from mono- to biallelic expression during mid-gestation and the Kcnq1ot1 ncRNA per se. I hypothesize that regulation by the Kcnq1ot1 ncRNA is not occurring in a uniform manner in the embryo; rather, the amount of regulation by the ncRNA is dependent on the developmental stage and specific tissue. In addition, this regulation involves complex interactions between enhancers, insulators and other regulatory elements to control the amount of silencing by the Kcnq1ot1 ncRNA. First, through a series of experiments looking at the Kcnq1 promoter, the mechanism of Kcnq1 paternal expression was determined. It was confirmed that Kcnq1 becomes biallelic during mid-gestation in the heart. Bisulfite mutagenesis and methylation sensitive chromatin immunoprecipitation were used to test the hypothesis that the Kcnq1 promoter was methylated in early development and then lost its methylation mark. However, a lack of methylation disproved this mechanism of paternal Kcnq1 activation. Rather, chromosome conformation capture (3C) determined that the Kcnq1 promoter interacts in a tissue-specific manner with regions within the domain that have enhancer activity. The role of the ncRNA within our system was also investigated. Interestingly, when Kcnq1ot1 allelic expression was profiled throughout development in heart, it transitioned to biallelic expression during heart development but remained monoallelic in the liver and brain. Several possibilities could account for this phenomenon, including loss of promoter methylation and/or an alternative transcript start site. Both of these options were explored using bisulfite mutagenesis and 5' RACE. However, the Kcnq1ot1 promoter region retained its methylation mark even after the maternal transcript was turned on, disproving this idea. Rather, a maternal specific transcript was found in the heart to start downstream of the CpG islands. Lastly, to gain a better understand of the Kcnq1ot1 ncRNA, experiments were carried out on a mutant mouse in which a truncated form of the ncRNA was transmitted paternally; this is dubbed the "Kterm" mouse. Unexpectedly, Kcnq1 still followed the same mono- to biallelic transition as seen in the wild-type, whereas the head and body counterparts from the same stage embryos were biallelic for Kcnq1. Also, the immediate upstream genes, Cdk1nc and Slc22a18, lost their mono-allelic expression in neonatal heart, liver and brain when the Kterm mutation was transmitted. This suggested that Kcnq1ot1 did not function as a silencer for Kcnq1 paternal expression in the heart, but rather had an alternative and previously unknown function. From qRT-PCR, 3C and ChIP assays, it was determined that the Kcnq1ot1 ncRNA plays a role in regulating Kcnq1 gene expression in the heart by limiting its interaction to specific cis-acting enhancers. When the ncRNA was absent, the Kcnq1 promoter interacted with non-native sites along the domain, possibly causing the increase in transcript expression. This phenomenon was specific to the heart and was not seen in other tissues. These findings showed that Kcnq1 paternal expression is the result of strong developmental and tissue specific enhancers. Chromatin interactions in cis put a strong enhancer in contact with the Kcnq1 promoter to increase its expression in later development. In addition, a truncation mutation model identified a key role for the Kcnq1ot1 ncRNA in regulating Kcnq1 expression. Instead of regulating the imprinting status of Kcnq1, the ncRNA regulates the amount of Kcnq1 transcript being produced in the heart by regulating chromatin interactions. Finally, these studies identified a maternally expressed Kcnq1ot1 transcript whose role in heart development is still not fully understood. Taken together, these findings support a model where an inhibitory factor(s) silence the paternal Kcnq1 transcript and maternal Kcnq1ot1 transcript and in later development, this factor is released allowing for expression and chromatin interactions to occur. / Molecular Biology and Genetics

Previous studies have shown that genes can be switched on or off by age, environmental factors, diseases, and lifestyles. The open or compact structures of chromatin is a crucial factor that affects gene expression. Epigenetics refers to hereditary mechanisms that change gene expression and regulations without changing DNA sequences. Epigenetic modifications, such as DNA methylation, histone modification, and non-coding RNA interaction, play critical roles in cell differentiation and disease processes. The conventional approach requires the use of a few million or more cells as starting material. However, such quantity is not available when samples from patients and small lab animals are examined. Microfluidic technology offers advantages to utilize low-input starting material and for high-throughput. In this thesis, I developed novel microfluidic technologies to study epigenomic regulations, including 1) profiling epigenomic changes associated with LPS-induced murine monocytes for immunotherapy, 2) examining cell-type-specific epigenomic changes associated with BRCA1 mutation in breast tissues for breast cancer treatment, and 3) developing a novel microfluidic oscillatory hybridized ChIRP-seq assay to profile genome-wide lncRNA binding for numerous human diseases. We used 20,000 and 50,000 primary cells to study histone modifications in inflammation and breast cancer of BRCA1 mutation, respectively. In the project of whole-genome lncRNA bindings, our microfluidic ChIRP-seq assay, for the first time, allowed us to probe native lncRNA bindings in mouse tissue samples successfully. The technology is a promising approach for scientists to study lncRNA bindings in primary patients. Our works pave the way for low-input and high-throughput epigenomic profiling for precision medicine development. / Doctor of Philosophy / Traditionally, physicians treat patients with a one-size-fits-all approach, in which disease prevention and treatment are designed for the average person. The one-size-fits-all approach fits many patients, but does not work on some. Precision medicine is launched to improve the low efficiency and diminish side effects, and all of these drawbacks are happening in the traditional approaches. The genomic, transcriptomic, and epigenomic data from patients is a valuable resource for developing precision medicine. Conventional approaches in profiling functional epigenomic regulation use tens to hundreds of millions cells per assay, that is why applications in clinical samples are restricted for several decades. Due to the small volume manipulated in microfluidic devices, microfluidic technology exhibits high efficiency in easy operation, reducing the required number of cells, and improving the sensitivity of assays. In order to examine functional epigenomic regulations, we developed novel microfluidic technologies for applications with the small number of cells. We used 20,000 cells from mice to study the epigenomic changes in monocytes. We also used 50,000 cells from patients and mice to study epigenomic changes associated with BRCA1 mutation in different cell types. We developed a novel microfluidic technology for studying lncRNA bindings. We used 100,000-500,000 cells from cell lines and primary tissues to test several lncRNAs. Traditional approaches require 20-100 million cells per assay, and these cells are infected by virus for over-producing specific lncRNA. However, our technology just needs 100,000 cells (non-over-producing state) to study lncRNA bindings. To the best of our knowledge, this is the first allowed us to study native lncRNA bindings in mouse samples successfully. Our efforts in developing microfluidic technologies and studying epigenomic regulations pave the way for precision medicine development.

Despite the existence of various molecular marker systems there are still limitations in distinguishing between closely related species based on molecular divergence, especially when hybridization events have occurred in the past. The characterisation of plant small nucleolar RNA (snoRNA) genes and their organisation into multigene clusters provides a potential nuclear marker system which could help in resolving the phylogenetic history of plants and might be applicable in DNA barcoding. Using closely and distantly related Senecio species, I investigated a combination of fragment length and sequence variation of snoRNA genes/snoRNA gene clusters to assess the utility of this marker system for barcoding and resolving species relationships. SnoRNA gene and gene cluster sequences identified in Arabidopsis thaliana were used to find homologues in other species and subsequently used for the design of universal primers. Most of the universal primer pairs designed were successful in amplifying snoRNA fragments in most Senecio species and fragment length variation between and within species could be detected. Furthermore, the combination of some fragment length datasets produced by different primer pairs enabled the separation of species and the detection of reticulate evolution indicating a high potential of snoRNA gene/gene cluster fragment length polymorphisms (SRFLPs) for phylogenetic reconstructions in Senecio and other plant genera. Most of the examined gene clusters showed a similar gene order in Senecio and Arabidopsis. However, the majority of these clusters appeared to exhibit more copies in Senecio, some of which were distinguishable by a combined sequencing/fragment profiling approach, and shown to be putative single copy regions with the potential to be used as co-dominant markers. However, a high number of paralogues and possible differences in copy number between species excludes these regions from being used in DNA barcoding. This is because specific primers would have to be developed for specific copies which would preclude development of a universal application for barcoding. None of the regions showed enough sequence variation to delimit distinctly closely related Senecio species and were therefore also considered to be unsuitable for DNA barcoding. Although most snoRNA genes and gene clusters might be inapplicable for DNA barcoding, they are likely to be valuable for phylogenetic studies of species groups, genera and families. On this scale, specific primers might act universally and the number of paralogous copies is likely to be equal across the species group of interest.

L'environnement des organismes vivants est par définition fluctuant, toutes variations aléatoires du milieu de vie constituent un stress pour les cellules. Au fil de l'évolution, une forte pression de sélection a façonné le fonctionnement cellulaire jusqu'aux réponses complexes élaborées par les organismes vivants. Mes travaux s'inscrivent autour des mécanismes moléculaires de la réponse au stress et plus particulièrement les stress génotoxiques. La première partie de l'étude décrit finement la réplication de l'ADN en condition de stress réplicatif. Ainsi, nous avons montré que les pools de dNTPs sont limitants pour la progression des fourches de réplication en phase S normale et en stress, et que leurs niveaux conditionnent le programme temporel de réplication. De plus, nous avons mis en évidence un mécanisme d'adaptation au stress réplicatif et aux dommages constitutifs dans des mutants caractérisés par de l'instabilité génétique (CIN) via l'activation du checkpoint de dommage conduisant à l'expansion des pools de dNTPs. Pour finir, nous montrons que l'augmentation des niveaux de dNTPs facilite la réplication en présence de lésions de l'ADN, d'une manière indépendante des ADN polymérases translésionnelles. Le second projet apporte de nouveaux éléments sur le rôle de Crt10 in vivo, préalablement identifié comme un régulateur transcriptionnel des gènes de la Ribonucléotide Réductase (RNR). Nos données indiquent que les mutants crt10Δ ont des niveaux de dNTP similaires à ceux des cellules sauvages, et que cette mutation a un très faible impact sur l'expression des gènes RNR, malgré un phénotype de vitesse de progression des fourches accrue. Nous montrons que le mutant crt10Δ est caractérisé par un défaut d'entrée en phase S et d'initiation des origines de réplication. L'origine de ce défaut pourrait résider dans les fonctions de Crt10 impliquant la régulation de la biosynthèse des ribosomes au sein du complexe Rtt101-Mms1. Le troisième projet identifie MRX (Mre11-Rad50-Xrs2) comme un acteur de la voie de terminaison des ARN non codants. MRX s'associe à des loci recrutant également le complexe de terminaison Nrd1-Nab3-Sen1 à l'échelle du génome entier. L'inactivation de RAD50 se traduit par une perte d'efficacité de terminaison et l'accumulation de transcrits bicistroniques, ainsi qu'une dérégulation du niveau d'ARNs non codants instables (CUT) et de leurs gènes associés. Tout comme Sen1, MRX pourrait intervenir dans la résolution des collisions entre les machineries de transcription et de réplication. / A fluctuating environment is a powerful mean of selection for living organisms, which evolved complex signaling networks to integrate these variations and direct swift and efficient cellular responses. The aim of my work is the identification and characterization of molecular mechanisms involved in the tolerance of replicative stress and DNA damage. First, we show that changes in dNTP pools affect several aspects of replication dynamics in budding yeast. dNTP levels are limiting for normal S-phase progression and determine the temporal program of replication during a replicative stress. Interestingly, we also observed that chromosomal instability (CIN) mutants display expanded dNTP pools due to the constitutive activation of the DNA damage checkpoint. Since increased dNTP levels promote forks progression in the presence of DNA lesions, we propose that CIN mutants adapt to chronic replicative stress by upregulating dNTP pools. Secondly, we bring new lights on the role of Crt10 in vivo, which has been initially identified as a negative regulator of Ribonucleotide Reductase (RNR) genes expression. Deletion of CRT10 neither leads to expanded dNTP pools, nor to a massive deregulation of RNR genes, although crt10Δ cells exhibit faster fork progression. The crt10Δ mutant accumulates at the G1/S transition and exhibits a strong defect of origin firing that could account for its replication phenotype. Moreover, we observed a global decrease in ribosome biogenesis in crt10Δ. The physical interaction of Crt10 with several members of the ribosome biogenesis pathway and its role in the Rtt101-Mms1 complex suggest that Crt10 may regulate ribosome levels in vivo. At last, we identified MRX (Mre11-Rad50-Xrs2) as a bona fide member of the transcription termination of non-coding RNA (ncRNA). ChIP-seq reveals that MRX localized at the same loci than the Nrd1-Nab3-Sen1 complex in vegetative growth. rad50Δ cells exhibit transcriptional read-through and upregulation of unstable cryptic transcripts (CUTs) leading to a misregulation of their associated gene. Finally, MRX seems to be involved in the resolution of branched structures emanating from collision between transcription and replication machineries, as it is the case for Sen1.

Les ARN non-codant (ARNnc) assurent différentes fonctions vitales permettant aux bactéries de s'adapter rapidement aux conditions changeantes de leur environnement L'analyse de données transcriptomiques de la souche Pseudomonas brassicacearum NFM421 en réponse à différents stress en utilisant des puces à ADN qui contiennent aussi bien les régions codantes que les régions non codantes a révélé la modulation de deux ARNnc potentiels en réponse à des métaux lourds (Cd et U), dénommés IrsZ et IrsY. De plus, le génome de P. brassicacearum a été entièrement séquencé et une centaine d'ARNnc potentiels a été identifié par l'utilisation d'outils bioinformatiques de prédiction d'ARNnc. Ce travail vise à caractériser les deux ARNnc potentiels, IrsZ et IrsY, et à déterminer leur fonction chez P. brassicacearum. L'analyse bioinformatique de leur séquence ne révèle pas d'homologue dans la base de données des ARNnc. Nous avons validé expérimentalement par différentes approches techniques l'expression des deux ARNnc candidats dans différentes conditions de cultures et sous différents stress. Ceci a conduit notamment à révéler la modulation par le fer de l'expression des deux ARNnc IrsZ et IrsY. Leur expression est fortement activée par de fortes concentrations en fer. Cependant, en réponse à un stress oxydant causé par le peroxyde d'hydrogène, l'expression des deux ARNnc est réprimée. Cette répression est exacerbée chez les bactéries surexprimant oxyR. Nos travaux semblent indiquer que IrsZ et IrsY agissent comme des senseurs du statut intracellulaire du fer. / Regulatory non-coding RNAs (ncRNA), act as regulators of translation and message stability. They modulate a wide range of physiological responses to environmental stimuli. Due to their biological interest, different bioinformatics tools and experimental approaches have been developed for detecting new ncRNA. Transcriptome analysis of the plan root-associated bacterium Pseudomonas brassicacearum NFM421 strain in response to various stresses, using microarrays containing coding as well as non-coding DNA fragments, revealed the modulation of two potentials ncRNA in response to heavy metals (Cd and U), named IrsZ and IrsY. Furthermore, P. brassicacearum genome was completely sequenced and hundreds of potentials ncRNA have been predicted by using computational tools. This work aims at characterizing the two potentials ncRNA, IrsZ and IrsY, and to determine their function in P. brassicacearum. No homologous was found in the ncRNA database. We validated the expression of the two potential ncRNA by different experimental approaches in different culture conditions and under different stresses. This led to reveal that both IrsZ and IrsY are modulated by iron. Their expression is strongly activated by high concentrations of iron. However, the expression of both Irs ncRNA is suppressed under oxidative stress generated by hydrogen peroxide. This repression is exacerbated in P. brassicacearum overexpressing oxyR. Our work suggests that IrsZ and IrsY act as sensors of intracellular iron status.